The development of extended-release formulations, such as exenatide ER using microsphere technology, represents a notable advancement in the pharmaceutical field
Yes from a medical safety point of view, you usually can
Moreover, a recent SURPASS-3 MRI substudy has shown that tirzepatide may be more effective in reducing liver fat than insulin degludec [93]
Individual outcomes are not guaranteed and depend on clinical eligibility, individual biology, and lifestyle factors
It is the single most important factor separating tirzepatide from retatrutide
ANCC Certified Doctor of Nursing FNP-C Kristi Richards, NP Nurse Practitioner Diabetes & Obesity Medicine Three decades of care, focused on diabetes management and preventing complications